The recent outbreak of Lassa fever at the 44 Nigerian Army Reference Hospital, Kaduna, prompted a collaborative response with Irrua Specialist Teaching Hospital, ISTH, and the Federal Ministry of Health and Social Welfare.
Prof. Reuben Eifediyi, Chief Medical Director, Irrua Specialist Teaching Hospital, ISTH, and lead of the response team, in an interview with News Agency of Nigeria, thanked the Ministry for providing the enabling environment for the prompt response.
NAN reports that on Feb. 24, the Nigeria Centre for Disease Control and Prevention confirmed that Lassa Fever was responsible for the death of three health workers and one patient at the 44 Nigerian Army Reference Hospital, Kaduna, (44 NARHK).
Four of the six blood samples from suspected cases at the hospital sent to the Bayero University Teaching Hospital, Kano, were confirmed for Lassa Fever, while 25 close contacts of all the cases were being monitored and were placed on prophylactics (preventive medication).
Eifediyi said that the outbreak resulted in the deployment of a specialised emergency response team, which was made up of experts in Lassa fever management and infection pprevention from ISTH.
He said that though there were initial challenges, including inadequate resources and staffing, the response team successfully contained the outbreak through real-time laboratory testing, isolation and treatment of confirmed cases.
“Real-time PCR testing was conducted, leading to the identification and treatment of confirmed cases. Three confirmed cases were successfully treated and discharged, with no further fatalities, “ he said.
He said that the incident underscored the importance of effective partnerships and rapid mobilisation of expertise in addressing public health emergencies.
He said that health workers at the hospital went through training on Infection Prevention and Control measures even as he recommended structural improvement, staffing, training, equipment provision and hygienic measures.
He also made recommendations for capacity building and the establishment of a biosafety molecular laboratory at the hospital.
NAN reports that Lassa fever is an acute viral hemorrhagic illness transmitted to humans through contact with food or household items contaminated by infected rodents or contaminated persons.
Its symptoms include fever, headache, sore throat, general body weakness, cough, nausea, vomiting, diarrhoea, muscle pain, chest pain.
In severe case, there are unexplainable bleeding from ears, eyes, nose, mouth, and other body openings.
